CPRX vs CUBE · P/E 18, rev $491.7M vs P/E 25, rev $1.07B
Catalyst Pharmaceuticals Inc (CPRX) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the CPRX and CUBE stock pages for the full models.
Not investment advice.